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In this thesis, several studies are described concerning the developmental and affective as-
pects of schizophrenia and bipolar disorder, in terms of where they differ and overlap, and 
how that potentially overlaps in the prodrome.  
Examination of the developmental and non-developmental risks of affective and non-
affective psychotic disorders has important diagnostic implications, which led us to include 
work focusing on examination of diagnostic likelihood ratios of developmental and non-
developmental risks in relation to the diagnoses of schizophrenia and bipolar disorder. This is 
discussed in Chapters 2 and 3.  
The study of the developmental domains of affective and non-affective psychosis was 
carried out by examining areas where they differ and overlap in genetic and environmental 
factors shared by these two disorders (Chapter 3). In addition, several aspects of the pro-
drome, in terms of the distinction between bipolar disorder and schizophrenia, were investi-
gated, examining the view that transition from subclinical states of psychometric risk in the 
general population to psychotic disorder can be viewed from the perspective of a psychosis 
continuum. In order to investigate this, aspects of the epidemiology of psychotic experiences 
in the general population, which may predict transition to various clinical psychotic disorders, 
was investigated (Chapter 4).  
In the above-mentioned studies, data pertaining to both the NEMESIS and the EDSP data 
were examined. Additionally, we examined evidence from the literature using the methodol-
ogy of qualitative and quantitative review of both observational and experimental studies.  
Our findings 
In Chapter 2, the developmental domains of affective and non-affective psychosis – in par-
ticular schizophrenia and bipolar disorder – were investigated. A common and well accepted 
position regarding the causes of psychiatric disorders, especially with schizophrenia, is the 
supposition of a multifactorial component (Johns & Van Os, 2001) similar to chronic physio-
logical disease such as diabetes or cardiovascular disease. In the case of schizophrenia and 
bipolar disorder, this generally is taken to indicate that apart from the genetic component – 
with reported heritabilities of around 80% for schizophrenia and bipolar disorder – environ-
mental factors may play a role as well. However, it is unclear what impact genetic and envi-
ronmental factors have in terms of attributable fraction within these highly heritable diag-
nostic constructs. It is also unclear to what extent genetic factors play in their contribution to 
domains generally taken to reflect aberrant neurodevelopment, such as brain structural 
alterations associated with these disorders. Since pathophysiological findings demonstrate 
that there are brain changes in most psychiatric disorders, we wanted to investigate to what 
extent there is a genetic contribution to the development of brain structures. We also want-
ed to see if this genetic influence is also the cause of the brain changes in schizophrenia, 
because the brain changes in schizophrenia have been investigated more extensively than in 
any other psychiatric disorder.  
In the first article, ‘Heritability of structural brain traits: an endophenotype approach to 
deconstruct schizophrenia’, a literature search on the heritability of brain structures in 
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healthy people, in people with schizophrenia and pedigrees was carried out. In this article, 
evidence from literature on the heritability of brain structures in healthy monozygotic twins 
was examined and the heritability rates in studies with monozygotic and dizygotic twins con-
cordant and discordant for schizophrenia were summarised in order to be able to estimate 
the contribution of genetic and environmental factors to brain structures. Examination of the 
contribution of genetic and environmental factors was also investigated in pedigree studies, 
in which the genetic component can be estimated more accurately as environmental factors 
are assumed to play a minor role in pedigree effects. In addition, the genes that may be in-
volved in these brain structures in the different subgroups were investigated.  
The following conclusions were drawn from the studies: the brain structures that were 
formed earlier in life and also the deeper structures were more genetically influenced than 
structures formed later in life, which are more environmentally influenced. The findings were 
similar for most of the brain structures across the different groups. However, there were also 
conflicting results in different studies on the same brain structures both in healthy people 
and in patients with schizophrenia. The brain changes in schizophrenia are present in about 
50% of the patients that are included in these neuroimaging findings. As for the genes under-
lying these effects on brain structures, there are not enough studies showing evidence for 
effects of specific genes on specific brain structures.  
The use of brain structures as an endophenotype may be valuable in deconstructing the 
genetics of brain traits in healthy people, people with schizophrenia and in pedigrees. Taking 
into account the limitations of neuroimaging as well of genetic epidemiological studies, and 
considering the problematic assumption that monozygotic twins share the (prenatal and 
postnatal) environment to the same degree as dizygotic twins, that most studies included 
rely on, the results of this review can only be described as helpful for further research in 
defining which brain structures might be more genetically influenced and represent genetic 
effects underlying the aetiology of schizophrenia. More research is necessary, and it is too 
early to state to what extent brain structural alterations represent the genetics of schizo-
phrenia, let alone bipolar disorder, in a meaningful way. 
In the second article, ‘Murray et al. (2004) revisited: is bipolar disorder identical to 
schizophrenia without developmental impairment?’, the developmental factors in the over-
lap or non-overlap between the two disorders, i.e. schizophrenia and bipolar disorder, were 
investigated in a qualitative review. The search was carried out by examining the evidence 
from the literature in the past ten years and by revisiting the view by Murray et al., who 
published an article in 2004 which advocated the view that bipolar disorder was identical to 
schizophrenia without, however, expression of developmental impairment.  
Most of the findings by Murray et al. (2004) are still relevant, according to our findings 
from the literature. An additional finding was that in the past ten years, more evidence has 
arisen that genetic risk for schizophrenia is expressed in part as neurocognitive impairments, 
whereas genetic risk for bipolar disorder is only mildly expressed with neurocognitive altera-
tions. General population studies show that both disorders have phenotypes that are associ-
ated with psychometric risk states in healthy individuals and that these psychometric states 
are similarly highly comorbid with each other. One other finding was that exposure to an 
urban environment impacts on specific developmental associations with schizophrenia which 
is not observed in bipolar disorder, although we did find in one of our analyses with the 
NEMESIS data (Chapter 3, first article), that urbanicity specifically impacts on the psychotic 
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but not on the affective dimension of bipolar disorder, suggesting dimension-specific effects 
across diagnostic categories.  
In the third article, ‘Extended psychosis phenotype – yes: single continuum – unlikely’, 
an alternative theory opposing the categorical view of psychiatric disorder, in the sense of ill 
versus not ill (in contrast to the use of continuum as denoting a lack of contrast between 
disorder categories within psychotic illness), e.g. the continuum theory of psychosis, was 
investigated conceptually in an attempt to clarify whether a population psychosis continuum 
or, perhaps better described as extended psychosis phenotype exists and, if so, how this ex-
tended psychosis phenotype is distributed fully or quasi-continuous, and what determines 
whether some people experiencing psychotic experiences develop psychotic disorders later 
in life whereas others do not. Until recently, research on syndromal clustering of dimensions 
of psychosis was carried out almost exclusively in the population of people already attending 
mental health services, based on the assumption that symptoms observed in patients with 
psychotic disorder naturally did not exist outside mental health services. However, general 
population studies are showing that syndromal clusters of psychotic and affective symptoms 
not only exist in populations attending mental health services, but also are expressed as 
extended phenotypes in the general population (Stip & Letourneau, 2009). In order to be 
able to make a conceptual shift from studying clusters of psychosis dimensions in mental 
health services to the general population, it may not be productive to consider populations 
inside and outside the hospital as different at the level of symptoms per se, but at the level of 
whether or not need for care has developed. Not every person with a psychotic symptom will 
develop a clinical need, resulting in a visit to a general practitioner or to psychiatric services.  
This subject is further investigated in the last article of chapter 4. We present in this arti-
cle the first meta-analysis to ever attempt to estimate which people, given a certain level of 
expression of the extended psychosis phenotype in the general population (i.e. not in highly 
selected high-risk samples) will develop need for care, help-seeking behaviour and diagnostic 
status. Data were extracted from all published longitudinal studies in non-help-seeking gen-
eral populations. We conclude that there are a number of variables predicting the transition 
of subclinical symptoms in general populations to clinical disorders. Not only the load of 
psychotic experiences is important, but also what type of coping the person develops, and 
the degree of persistence of these subclinical psychotic symptoms over time. We further 
suggested a new model for research across the psychotic spectrum, suggesting that there is a 
psychosis continuum, but not a single psychosis continuum.  
In Chapter 3, studies concerning the affective domains of psychosis are presented. In the 
first two articles, NEMESIS data were analysed, in search for evidence for overlap (or non-
overlap) between affective and non-affective psychosis. In the first article, ‘Evidence that the 
urban environment specifically impacts on the psychotic but not the affective dimension of 
bipolar disorder’, urbanicity as an environmental risk factor for bipolar disorder was investi-
gated, because reports on this issue have been inconsistent, whereas high rates of psychotic 
disorders have already been shown in numerous studies related to the urban environment. 
Our hypothesis was that any effect of urbanicity on the bipolar phenotype would be moder-
ated by comorbid psychotic symptoms. The cumulative incidence of bipolar and psychotic 
symptoms and syndromes – assessed with the CIDI in relation to five levels of population 
density of place of residence – were examined. In addition, we examined the degree of co-
morbidity between broadly and narrowly defined bipolar phenotypes on the one hand and 
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the dichotomous presence of broadly (17.2%) and narrowly (3.8%) defined psychotic symp-
toms on the other, as a function of population density of place of residence.  
Higher rates of bipolar disorder, however defined, were observed in more urbanized ar-
eas, as well as a strong interaction between comorbid psychosis and level of urbanicity, indi-
cating that with greater degree of psychotic comorbidity, a greater effect size of the urban 
environment was observed. For bipolar disorder without psychosis, no effect of urbanicity 
was apparent. These results suggest differential environmental causal effects on affective 
and psychotic dimensions of bipolar psychopathology.  
Given the fact that associations with urbanicity are thought to reflect the impact of an 
environmental exposure that interacts with genetic liability to produce illness (Van Os, 
2003a, 2003b, 2004), these results should be examined in light of previous work in the field 
of both molecular genetics and genetic epidemiology that has shown that there is a substan-
tial sharing of genetic risk between bipolar disorder and non-affective psychosis (Cardno et 
al., 2002; Berrettini W, 2003a, 2003b). This means that when two individuals have a similar 
amount of shared genetic liability for both bipolar disorder and schizophrenia, the one that 
becomes exposed to an urban environment may develop a more psychotic illness, whereas 
the one not exposed to an urban environment may develop a more mania-only illness, sug-
gesting that within the bipolar spectrum the impact of urban environment on the occurrence 
of more psychotic illness may be mediated by a different pathway than the rate of more 
mania-only illness. These mechanisms of gene-environment interaction have also been de-
scribed for other psychiatric disorders such as depression and anxiety, two conditions that 
have been shown to share genes that, however, produce differential outcomes depending on 
subsequent exposure to divergent environmental risk factors, some resulting in anxiety out-
comes and other in depression (Kendler et al., 1987, 1992, Kendler, 1996).  
In the second article, ‘The impact of subclinical psychosis on the transition from sub-
clinical mania to bipolar disorder’, the prevalence of subclinical psychotic and manic symp-
toms was investigated, in terms of how these subclinical population phenotypes co-vary with 
and impact on each other. Again, NEMESIS data were used and the degree of comorbidity 
between subclinical mania and subclinical psychosis was investigated. In addition, the impact 
of subclinical comorbidity on social impairment and on the transition from subclinical mania 
to onset of bipolar disorder was also investigated.  
The lifetime prevalences of at least one manic and one psychotic symptom were 4.1% 
and 4.2%, respectively, but, after excluding the people with DSM-III-R diagnoses of bipolar 
disorder or psychotic disorder, these prevalences were 2.3% (subclinical mania) and 2.8% 
(subclinical psychosis). Regarding the question as to how these phenotypes co-vary with each 
other, it was found that individuals with subclinical mania had a 17% risk of subclinical psy-
chosis, compared to 2.3% in those without (p < 0.000). Subclinical psychosis in individuals 
with subclinical mania was much more predictive of a future diagnosis of bipolar disorder. As 
for social impairment, there was a positive interaction between social impairment due to 
physical and psychological problems and subclinical psychosis, indicating that for a given 
level of subclinical mania, the coexistence of subclinical psychotic symptoms was more pre-
dictive of social impairment, although this statistical interaction was not significant.  
Thus, the subclinical phenotypes of mania and psychosis are more prevalent than their 
clinical counterparts and cluster together. One of the mechanisms by which the clustering of 
subclinical mania and subclinical psychosis may be relevant for clinical outcomes is that pos-
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sibly the formation of more toxic combinations of subclinical mania and subclinical psychosis 
may facilitate a higher transition to bipolar disorder. A better understanding of this pathway 
is crucial for the development of early intervention.  
The study is important in showing that subclinical symptoms should not be neglected, 
since they result in higher transition rates from subclinical to clinical disorders; specifically 
the comorbidity of psychotic symptoms may be toxic in this regard. Subclinical phenotypes 
can be seen as intermediary phenotypes of a mood continuum that after exposure to addi-
tional risk factors may progress to a full-blown disorder (Hanssen et al., 2005), specifically in 
the presence of psychotic symptoms at the subclinical level. 
In the third article, ‘Evidence that patients with single versus recurrent depressive epi-
sodes are differentially sensitive to treatment discontinuation: a meta-analysis of placebo-
controlled randomized trials’, the focus was on the maintenance treatment of depression, as 
a paradigm for sensitisation. Antidepressants are effective in the treatment of depression, 
but also in prevention of relapse after remission from an acute episode. It is unclear though, 
to what extent the prophylactic effect of antidepressants is moderated by the duration of the 
continuation phase, level of abruptness of antidepressants discontinuation, or the number of 
previous episodes. This study attempted to address these questions.  
All published randomized, placebo-controlled, double-blind clinical trials available before 
May 2007 were identified that addressed the efficacy of continuation or maintenance treat-
ment of major depressive disorder with either SSRIs or TCAs and included patients entering a 
maintenance phase after achieving remission from the acute phase.  
The conclusions were that the overall reduction of relapse risk in the maintenance phase 
was highly significant for both SSRIs and TCAs over one year of follow-up of maintenance 
treatment. Treatment with an antidepressant results in approximately 70% reduction of risk 
of relapse, confirming previous findings by Loonen et al. (1991), Geddes et al. (2003) and 
Viguera et al. (1998). The prophylactic effect appeared to be constant over the length of the 
continuation phase. The major conclusion in this study was that recurrent episode patients 
experience less protection from antidepressants over the maintenance phase than single 
episode patients. This suggests that with increasing number of episodes, patients may de-
velop a relative resistance against prophylactic properties of antidepressant medication. 
There was no difference between abrupt discontinuation of antidepressants versus gradual 
discontinuation on relapse rates, except for a particular subgroup of recurrent episode pa-
tients, for which the mode of discontinuation was important. In these patients, abrupt dis-
continuation may lead to a relapse, a problem that has been identified for lithium as well. 
This finding may be interpreted in the context of sensitisation or a kindling-like process, in 
which biochemical and physiological processes involved in the illness become progressively 
more easily triggered by the same circumstances or precipitants.  
We develop the hypothesis that sensitisation, as a form of progressive behavioural sensi-
tisation, would be evident in depressive disorder manifested by evidence of decreased re-
sponse to treatment with an increasing number of depressive relapses. However, the sensiti-
sation model may not only be applicable to depression. There is accumulating evidence that 
behavioural sensitisation may also be relevant for psychotic disorder and in particular for 
positive symptoms in psychotic disorders (Collip et al., 2010). In other words, sensitisation 
may be important for the affective pathway in psychotic disorder (Myin-Germeys & Van Os, 
2007). Future studies should take this issue further, possibly focusing on both affective and 
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psychotic symptoms in psychotic disorder, also in relation to antidepressant treatment in this 
group. 
In Chapter 4, we described to what extent findings in the literature and research in psy-
chiatry on developmental and affective domains of psychosis are applicable to the prodrome. 
Research on the prodrome is important because it is known that disorders such as schizo-
phrenia or bipolar disorder do not have a sudden onset. In many patients, the first episode is 
preceded by a lengthy pre-phase in which symptoms manifest themselves in attenuated form 
for prolonged periods, sometimes as long as years. These trajectories may be amenable to 
early intervention, in order to reduce the psychological, social and possibly biological disrup-
tion that can lead to poor outcome (Pantelis et al., 2003).  
Although there are many studies on the prodrome, these may be biased to a degree due 
to the vagaries of the selection processes that underlie the ultra-high-risk samples. More-
over, there is considerable confusion about the meaning conveyed by the term at risk mental 
state.  
In the first article, ‘DSM-V and the ‘Psychosis Risk Syndrome’: Babylonic confusion’, the 
focus is on whether DSM-V should consider the inclusion of a new category, called the psy-
chosis risk syndrome – or possibly the related term attenuated psychotic symptoms syn-
drome. We make the point that this should not occur, since risk is not an appropriate term in 
this context because subjects already, by definition, have a need for care, and the predictive 
value in even ultra-high-risk samples is too low for use in clinical practice.  
In the second article, ‘The case of the missing evidence: what do subclinical psychosis 
spectrum experiences predict in unselected representative population samples? A system-
atic review enriched with new results’, a meta-analysis on psychotic experiences in the gen-
eral population is presented, with a specific focus on unselected general population samples 
with psychotic experiences that are at risk of making the transition to a clinical disorder. The 
yearly risk of conversion to a clinical psychotic outcome in exposed individuals (0.56%) was 
3.5 times higher than for individuals without psychotic experiences (0.16%). Conversion to a 
clinical disorder increased with the number, certainty, frequency, persistence and degree of 
affective dysregulation of psychotic experiences. The major finding in this study was the 
discrepancy between the 10% conversion rate in the high-risk literature compared to the 
actual 0.56% conversion rate in unselected population-based samples. The explanation for 
the discrepancy lies in the sample enrichment strategies through community awareness 
campaigns and other selective inclusion methods by which people participating in these high-
risk studies are selected, creating a very high density of risk. The high conversion rates of the 
high-risk early intervention studies thus are based on sample enrichment strategies, rather 








Deze thesis behandelt verschillende onderzoeken naar een mogelijke overlap van schizo-
frenie en bipolaire stoornis. We zijn uitgegaan van de klassieke diagnoses van schizofrenie 
(niet-affectieve psychose) en bipolaire stoornis (affectieve psychose), zoals geclassificeerd in 
de diagnostische handboeken DSM-IV en ICD-9 (Hoofdstuk 1). In de affectieve psychose staat 
de stemmingscomponent op de voorgrond, terwijl in de niet-affectieve psychose de cogniti-
eve component de hoofdrol speelt. We hebben naar een eventuele overlap, of juist een ge-
brek daaraan, gezocht op een tweetal domeinen van de affectieve en niet-affectieve psy-
chose, nl. het ontwikkelings- en het affectieve domein; verder hebben we gekeken hoe deze 
domeinen van invloed zijn op de prodromale fase van de twee stoornissen.  
Bevindingen 
In hoofdstuk 2 begonnen we met het ontwikkelingsdomein van de affectieve en niet-
affectieve psychoses, in het bijzonder keken we naar de diagnoses bipolaire stoornis en schi-
zofrenie. We deden dit aan de hand van 3 artikelen.  
Een theorie met brede consensus over de oorzaken van psychiatrische aandoeningen is, 
dat het ontstaan kan worden teruggevoerd op een multifactoriële aetiologie, d.w.z. dat er 
meerdere factoren bijdragen aan het ontstaan van de aandoening. Schizofrenie en bipolaire 
stoornis kennen een erfelijkheid van rond de 80%, maar onduidelijk is hierin de bijdrage van 
gen/omgevingsinteracties. De genetische contributie als oorzakelijke factor kan tot expressie 
komen in de ontwikkeling van het brein en worden onderzocht met beeldvormend onder-
zoek van de hersenen van patiënten met schizofrenie in vergelijking met (i) hun broers/ zus-
ters/familieleden en (ii) gezonde controlepersonen.  
Omdat de ontwikkelingsneurologische breinveranderingen het beste onderzocht zijn in 
de schizofrenie, hebben we in het eerste artikel van hoofdstuk 2, Heritability of structural 
brain traits: an endophenotype approach to deconstruct schizophrenia, een literatuurstudie 
gedaan naar de erfelijkheid van breinstructuren in 1) gezonde personen, 2) personen met 
schizofrenie en 3) niet-menselijke primaten, om zo een conclusie te kunnen trekken over de 
invloed van genetische en omgevingsfactoren op breinstructuren. Daarnaast hebben we 
gekeken of er genen zijn die bij de ontwikkeling van specifieke breinstructuren betrokken 
zijn.  
 
We kwamen tot de volgende conclusies: 
1)  De breinstructuren die vroeg in het leven ontwikkeld zijn, of die diep in het brein liggen, 
ondervinden meer invloed van genetische factoren dan breinstructuren die later in het 
leven gevormd zijn en meer worden beïnvloed door omgevingsfactoren.  
2)  In de gepubliceerde onderzoeken zijn tot op heden geen specifieke genen gevonden die 
coderen voor specifieke breinstructuren; er is nog maar weinig onderzoek verricht op 
dit gebied.  
3)  Ondanks de beperkingen van neuroimaging en genetisch onderzoek, kunnen de bevin-
dingen tot nu toe als leidraad dienen voor verder onderzoek naar genetische oorzaken 
die aan de basis van schizofrenie liggen. 
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In het tweede artikel, Murray et al. (2004) revisited: is bipolar disorder identical to schi-
zophrenia without developmental impairment, hebben we gekeken naar een mogelijke 
overlap (of juist gebrek daaraan) van ontwikkelingsfactoren bij enerzijds schizofrenie en an-
derzijds bipolaire stoornis. De volgende conclusies konden worden getrokken: 
1)  De bipolaire stoornis is in vele opzichten “identiek” aan schizofrenie, maar mist, of ver-
toont in veel mindere mate, de ontwikkelingsneurologische beperkingen die de schizo-
frenie kenmerken zoals beschreven door Murray et al, 2004. 
2)  Uit de onderzoeken van de afgelopen 10 jaar komt naar voren dat het genetische risico 
op schizofrenie onder meer tot expressie komt als neurocognitieve beperking, terwijl 
dat bij de bipolaire stoornis veel minder het geval is. 
3)  Urbanisatie (leven in de grote stad) als omgevingsfactor heeft invloed op het voorko-
men van de ontwikkelingsneurologische stoornis schizofrenie, maar niet op het voor-
komen van bipolaire stoornis. 
 
In het derde artikel, Extended psychosis phenotype-yes: single continuum-unlikely, is de 
zogenaamde continuümtheorie van psychosen onderzocht en is getracht een conceptueel 
model te maken van een dergelijk psychosecontinuüm (in de zin van overlap met de normale 
mentale gesteldheid in de algemene populatie; ook wel extended psychosis continuum ge-
noemd): wat maakt dat sommige mensen over het continuüm bewegen van lage waarden 
naar de hogere, klinische relevante expressiewaarden van psychose? Hiertoe werd onder 
andere een meta-analyse uitgevoerd (zie hieronder). 
De conclusies die getrokken werden uit dit onderzoek zijn:  
1)  Er zijn meerdere variabelen die de overgang van subklinische symptomen in de algeme-
ne bevolking naar een klinische stoornis kunnen verklaren. 
2)  Niet alleen de hoeveelheid psychotische ervaringen, en hun frequentie, zijn belangrijk, 
maar ook wat voor soort mechanismen iemand ontwikkelt om hiermee om te gaan, 
alsmede de mate van persistentie (duur) van de klachten over de tijd. 
3)  Op basis van de huidige gegevens in de literatuur valt nog niet met zekerheid te zeggen 
of er werkelijk sprake is van een lineair continuüm, of dat er toch mogelijk kwalitatieve 
verschillen optreden op het uiterste einde van het continuüm. 
 
In hoofdstuk 3 zijn affectieve (stemmings-) domeinen van psychose onderzocht aan de hand 
van 3 artikelen. In de eerste twee artikelen zijn data van de NEMESIS-studie geanalyseerd en 
is er onderzoek gedaan naar evidentie van overlap (of gebrek aan overlap) tussen affectieve 
en niet-affectieve psychoses. 
 
In het eerste artikel, Evidence that the urban environment specifically impacts on the psy-
chotic but not on the affective dimension of bipolar disorder, is onderzoek gedaan naar 
wonen in de stad als omgevingsrisicofactor bij bipolaire stoornissen.  
De conclusie van de analyses was dat urbaniteit invloed heeft op het voorkomen van bi-
polaire stoornis, maar alleen in samenhang met psychotische comorbiditeit: het voorkomen 
van bipolaire stoornis zonder psychose is niet afhankelijk van de mate van stedelijkheid van 
de omgeving. Bij gelijke genetische kwetsbaarheid kan blootstelling aan urbaniteit dus meer 
schade aanrichten op het ontwikkelingsneurologisch domein.  
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In het tweede artikel, The impact of subclinical psychosis on the transition from subclinical 
mania to bipolar disorder, is de prevalentie van subklinische psychotische en manische 
symptomen onderzocht, met name hoe deze subklinische symptomen covariëren en op wel-
ke manier ze elkaar beïnvloeden.  
De conclusies waren: 
1)  Subklinische manie in aanwezigheid van subklinische psychotische symptomen is meer 
voorspellend voor een toekomstige diagnose van bipolaire stoornis (is dus meer 
“toxisch” voor het beloop). 
2)  Er is een suggestieve positieve interactie tussen het optreden van sociale beperkingen 
in het kader van medisch-psychiatrische aandoeningen en subklinische psychose; de 
aard van de interactie was dat voor een gegeven niveau van subklinische manie, de  
(co-) aanwezigheid van subklinische psychotische symptomen meer voorspellend is 
voor het optreden van sociale beperkingen. 
  
In het derde artikel, Evidence that patients with single versus recurrent depressive episodes 
are differentially sensitive to treatment discontinuation: a meta-analysis of placebo-
controlled randomized trials, is via de methode van de meta-analyse het fenomeen van de 
progressieve sensitisatie bij affectieve dysregulatie nader onder de loep genomen. Het on-
derzoek richtte zich op de onderhoudsbehandeling van depressies. Antidepressiva zijn effec-
tief in behandeling van acute depressies en in het voorkomen van terugval na een acute fase 
(‘relapse’). De vraag van het onderzoek was met name of de hoeveelheid eerdere depressie-
ve periodes de beschermende effecten van antidepressiva kunnen beïnvloeden, wat compa-
tibel is met het idee van progressieve sensitisatie: de kans om depressief te worden naar 
aanleiding van een zelfde hoeveelheid stress wordt met het verstrijken van de tijd steeds 
groter omdat het individu gesensitiseerd is. De conclusie van de meta-analyse was inderdaad 
dat patiënten die eerdere depressieve periodes achter de rug hebben, minder profiteren van 
het profylactisch (beschermend) effect van antidepressiva dan patiënten die een eerste peri-
ode van depressie doormaken. Dit kan worden verklaard door ‘sensitisatie’ of ‘kindling-like’ 
processen: door de ontstane gevoeligheid worden de biochemische en fysiologische proces-
sen die tot de ziekte leiden gemakkelijker in gang gezet. Gezien het feit dat affectieve dysre-
gulatie een kerncomponent is van psychose, verwachten we dat deze sensitisering ook een 
rol speelt bij psychose. 
 
In hoofdstuk 4 wordt aan de hand van 2 artikelen beschreven in welke mate de bevindingen 
uit de literatuur over de ontwikkelings- en affectieve domeinen van psychoses, toe te passen 
zijn op de prodromale fase. Onderzoek van de prodromale fase is erg belangrijk, omdat 
stoornissen als schizofrenie of bipolaire stoornissen meestal niet een plotselinge start of 
ontstaan kennen, maar vaak een lange prodromale fase hebben, waarin vroege interventie 
mogelijk is. Er is veel onderzoek gedaan naar deze prodromale fase, maar de onderzoeken 
geven mogelijk een vertekend beeld (bias) vanwege een idiosyncratische selectie van ‘ultra-
high risk’ populaties, waardoor de voorspellende waarde meer wordt bepaald door de selec-
tieve samenstelling van de onderzochte groep dan door ‘ultra high risk’- criteria, met name 
attenuated psychotic symptoms. Echter wat nu de voorspellende waarde van attenuated 
psychotic symptoms in de algemene populatie is, blijft onbekend.  
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In het eerste artikel, DSM-5 and the ‘Psychosis Risk Syndrome’: Babylonic confusion, wordt 
de DSM-V (in opzet) nader bekeken, met name wat betreft de eventuele inclusie van een 
psychosis risk syndrome (of mogelijk de daaraan verwante term attenuated psychotic symp-
toms syndrome). We tonen aan dat dit mogelijk verkeerd zou zijn, met name vanwege de 
boven beschreven selective sampling in de onderzoeken en het verkeerde gebruik van het 
woord "risk" in psychosis risk syndrome. 
 
In het tweede artikel, The case of the missing evidence: what do subclinical psychosis spec-
trum experiences predict in unselected representative population samples? A systematic 
review enriched with new results, wordt een meta-analyse uitgevoerd met betrekking tot 
psychotische ervaringen in niet-geselecteerde representatieve populaties uit de algemene 
bevolking, en de voorspellende waarde van deze ervaringen voor het ontstaan van een psy-
chotische stoornis. De conclusies waren dat: 
1)  het jaarlijkse risico op het ontwikkelen van een psychotische stoornis bij mensen met 
een of meer subklinische psychotische ervaringen (0,56%) 3,5 keer hoger is dan voor 
mensen zonder een psychotische ervaring, 
2)  het risico op transitie van subklinische psychotische ervaring naar psychotische stoornis 
toeneemt met aantal, frequentie, persistentie en mate van affectieve dysregulatie van 
de psychotische ervaringen, 
3)  de hoofdbevinding van de studie is de discrepantie tussen het 10% jaarlijkse transitieri-
sico uit de ultra high risk- literatuur en het 0,56% transitierisico in ongeselecteerde al-
gemene bevolkingsonderzoeken. De verklaring voor deze forse discrepantie ligt ons in-
ziens in de manier van selective sample enrichment die wordt toegepast in de ultra-high 
risk- onderzoeken maar onterecht wordt toegeschreven aan psychopathologische ‘ul-
tra-high risk’ -criteria. 
Toekomstige ontwikkelingen 
Naar aanleiding van onze publicaties en literatuurgegevens kan geadviseerd worden om de 
psychotische stoornis, zowel affectieve als niet-affectieve, multidimensioneel te benaderen; 
dit vanwege de beperkingen die een categorale indeling van psychiatrische stoornissen met 
zich meebrengt voor de dagelijkse klinische praktijk, voor wetenschappelijk onderzoek in de 
psychiatrie en voor de hanteerbaarheid van deze diagnoses voor patiënten en familieleden. 
Daarbij kan worden uitgegaan van verschillende symptoomdimensies, die cross-sectioneel in 
verschillende mate en in verschillende combinaties aanwezig zijn in verschillende individuen, 
zoals voorgesteld door Van Os en collega’s in een recente publicatie (Nature, 2010). In dit 
multidimensionele model kan uitgegaan worden van in ieder geval vier symptoomdimensies 
in het psychosesyndroom: affectieve dysregulatie (depressie, manie, angst), psychose (wa-
nen, hallucinaties), negatieve symptomen (o.a. verminderde motivatie) en cognitieve veran-
deringen. In de algemene bevolking zijn lage gradaties van deze vier symptoomdimensies ook 
aanwezig, die beschouwd kunnen worden als de expressie van genetische en niet-genetische 
kwetsbaarheid voor psychose (prevalentie van rond de 10-20%). In plaats van ons vast te 
bijten op de erfelijkheid van grote en vage diagnostische entiteiten zoals schizofrenie, waar-
bij onduidelijk is welk deel van het erfelijkheidspercentage werkelijk door genetische facto-
ren wordt bepaald en welk deel door gen/omgevingsinteractie, is het misschien beter om de 
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erfelijkheid van deze vier symptoomdimensies apart te bepalen. De symptoomdimensies zelf 
tonen matig tot hoge erfelijkheidspercentages, variërend van 40% erfelijkheid voor affectieve 
dimensies tot 40-60% erfelijkheid voor cognitieve dimensies.  
Toekomstige onderzoekslijnen zouden de genetische en epidemiologische aspecten van 
het psychosespectrum moeten integreren; genetische epidemiologie zou het relevante feno-
type (of de symptoomdimensie) moeten koppelen aan variabelen van timing, ernst en in-
vloed van omgevingsfactoren, in een en dezelfde studieopzet. Dat betekent dat populatieco-
hortonderzoeken gecombineerd zouden kunnen worden met klinische onderzoeken om zo 
alle syndromen van het klinische en niet-klinische spectrum bij elkaar te brengen. Op deze 
manier zou het moleculair genetisch onderzoek (zoals Genome-wide association studies 
[GWAS] en de speurtocht naar zeldzame varianten met grote of kleine effecten) gecombi-
neerd kunnen worden met onderzoek naar omgevingsfactoren, en gen/omgevingsinteracties 
in kaart kunnen worden gebracht. 
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